- Available:In stock228
- Availability date:2020-07-30
- Dosage form:Ointment
- In stock:228 Items
oxolin-darnitsa is an antiviral agent for external use. possesses virusocidal activity, blocking the binding sites of the influenza virus (mainly type A2) with the surface of the cell membrane, protects cells from the penetration of the virus into them. viruses of herpes simplex, herpes zoster, adenoviruses, viruses of infectious warts and molluscum contagiosum are also sensitive to oxolin.
Pharmacokinetics The drug is non-toxic, with topical application of the systemic effect is not detected, the body does not accumulate. When applied to the mucous membrane, 20% of the drug is absorbed, excreted mainly by the kidneys within 1 day.
Influenza prophylaxis, treatment of viral rhinitis.
Influenza prophylaxis: ointment is applied to the nasal mucosa daily 2-3 times a day for 25 days or in contact with patients.
Treatment of viral rhinitis: ointment is applied to the nasal mucosa 2-3 times a day for 3-4 days.
Individual hypersensitivity to the active substance or other components of the drug.
At the place of application of the ointment, a burning sensation may occur, which quickly passes; rhinorrhea; staining of the mucous membrane in blue.
Use during pregnancy and lactation. There are no data on the safety and effectiveness of the drug during pregnancy and lactation. the drug is undesirable to use during pregnancy and lactation.
Children. There are no data on the safety and efficacy of the drug in children.
The ability to influence the reaction rate when driving vehicles or working with other mechanisms. Oxolin does not affect the rate of neuromuscular conduction; in recommended doses, it can be used in persons driving vehicles and working with complex mechanisms.
The simultaneous intranasal use with adrenomimetic intranasal drugs can lead to an overdrying of the nasal mucosa.
No cases of overdose have been reported to date.
Symptoms: a burning sensation of the nasal mucosa and rhinorrhea is possible.
Treatment: stop using the ointment, rinse the remnants of the product with warm water.
In the original packaging at a temperature not exceeding 8 ° C.